.jpg)
.jpg)
.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Earlier this month, Ian Lipkin, M.D., and his team at Columbia University submit...
Over the last three years, the FDA has approved six new drugs for hemophilia. An...
After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, open...
Pharma Marketing in 2025: A Conversation with Fierce Pharma
Today, the U.S. Food and Drug Administration approved a novel treatment for hemo...
FRIDAY, March 28, 2025 -- Patients with takotsubo syndrome have increased risk ...
FRIDAY, March 28, 2025 -- Open-label placebo (OLP) provided with a treatment ra...
FRIDAY, March 28, 2025 -- A high proportion of women seem to undergo mammograph...
FRIDAY, March 28, 2025 -- In a position statement issued by the American Academ...
FRIDAY, March 28, 2025 -- New mothers are encouraged to engage in two hours per...
FRIDAY, March 28, 2025 -- Combination lipid-lowering therapy (LLT) is associate...
FRIDAY, March 28, 2025 -- For patients with chronic obstructive pulmonary disor...
FRIDAY, March 28, 2025 -- Bilateral oophorectomy is associated with an increase...
Many HHS department heads and staff were unaware of plans to fire some 10,000 em...
Key regulators are not recommending Lilly’s Kisunla be cleared for the European ...
Human medicines European public assessment report (EPAR): Lydisilka, estetrol,dr...
After failing to pass muster with England’s drug reimbursement watchdog earlier ...
Visby's kit includes vaginal self-collection swabs and a palm-sized, PCR-based t...
Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Da...
Gilead CEO Daniel O’Day saw another rise in his pay in 2024, reflecting the stea...
As U.S. President Donald Trump threatens a new round of tariffs as part of an on...
Human medicines European public assessment report (EPAR): Ontilyv, opicapone, Da...
Utah has become the first state to ban fluoride in public drinking water, despit...